Article Cited by others


Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy

Wang Fu-Bo, Chen Rui, Ren Shan-Cheng, Shi Xiao-Lei, Zhu Ya-Sheng, Zhang Wei, Jing Tai-Le, Zhang Chao, Gao Xu, Hou Jian-Guo, Xu Chuan-Liang, Sun Ying-Hao

Year : 2017| Volume: 19| Issue : 2 | Page no: 238-243

   This article has been cited by
1 Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
Tasmania del Pino-Sedeño, Diego Infante-Ventura, Aythami de Armas Castellano, Pedro de Pablos-Rodríguez, Antonio Rueda-Domínguez, Pedro Serrano-Aguilar, María M. Trujillo-Martín
European Urology Open Science. 2022; 46: 105
[Pubmed]  [Google Scholar] [DOI]
2 Long noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis
Yexin Li, Chunmeng Wei, Caihong Huang, Qiang Ling, LuLu Zhang, Shengzhu Huang, Naikai Liao, Weixia Liang, Jiwen Cheng, Fubo Wang, Linjian Mo, Zengnan Mo, Longman Li
Biomarkers. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
Fei Liu, Xiaolei Shi, Fangming Wang, Sujun Han, Dong Chen, Xu Gao, Linhui Wang, Qiang Wei, Nianzeng Xing, Shancheng Ren
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
4 Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
Milena Matuszczak,Jack A. Schalken,Maciej Salagierski
Cancers. 2021; 13(13): 3373
[Pubmed]  [Google Scholar] [DOI]
5 A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
Yun Li,Jin Ji,Ji Lyu,Xin Jin,Xing He,Shaojia Mo,Huan Xu,Jingyi He,Zhi Cao,Xi Chen,Yalong Xu,Lei Wang,Fubo Wang
Cancers. 2021; 13(16): 4075
[Pubmed]  [Google Scholar] [DOI]
6 Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen?
Edward K. Chang,Adam J. Gadzinski,Yaw A. Nyame
Asian Journal of Urology. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 A review of current clinical biomarkers for prostate cancer: towards personalised and targeted therapy
Ernest Osei,Steph Swanson
Journal of Radiotherapy in Practice. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
8 Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
Marek Samec,Alena Liskova,Lenka Koklesova,Samson Mathews Samuel,Kevin Zhai,Constanze Buhrmann,Elizabeth Varghese,Mariam Abotaleb,Tawar Qaradakhi,Anthony Zulli,Martin Kello,Jan Mojzis,Pavol Zubor,Taeg Kyu Kwon,Mehdi Shakibaei,Dietrich Büsselberg,Gustavo R. Sarria,Olga Golubnitschaja,Peter Kubatka
EPMA Journal. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review
Jude O Okoye
Avicenna Journal of Medicine. 2020; 10(03): 93
[Pubmed]  [Google Scholar] [DOI]
10 Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer
Lin Chunhua,Haiwei Zhao,Huishan Zhao,Youyi Lu,Jitao Wu,Zhenli Gao,Guojun Li,Yulian Zhang,Ke Wang
Translational Oncology. 2018; 11(3): 628
[Pubmed]  [Google Scholar] [DOI]
11 A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA ‘grey zone’
Jennifer Creed,Laurence Klotz,Andrew Harbottle,Andrea Maggrah,Brian Reguly,Anne George,Vincent Gnanapragasm
World Journal of Urology. 2017;
[Pubmed]  [Google Scholar] [DOI]
12 Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10?ng/mL
Yongqiang Zhou,Yun Li,Xiangnan Li,Minjun Jiang
BioMed Research International. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article